These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34896650)

  • 1. Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies.
    Damoiseaux J; Dotan A; Fritzler MJ; Bogdanos DP; Meroni PL; Roggenbuck D; Goldman M; Landegren N; Bastard P; Shoenfeld Y; Conrad K
    Autoimmun Rev; 2022 Mar; 21(3):103012. PubMed ID: 34896650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients.
    Philippot Q; Bastard P; Puel A; Casanova JL; Cobat A; Laouénan C; Tardivon C; Crestani B; Borie R
    Respir Res; 2023 Mar; 24(1):87. PubMed ID: 36941652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
    Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
    Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
    Vahabi M; Ghazanfari T; Sepehrnia S
    Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SARS-CoV-2 infection and autoimmunity].
    Meyer-Bahlburg A
    Z Rheumatol; 2024 Feb; 83(1):34-40. PubMed ID: 38108865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona.
    Solanich X; Rigo-Bonnin R; Gumucio VD; Bastard P; Rosain J; Philippot Q; Perez-Fernandez XL; Fuset-Cabanes MP; Gordillo-Benitez MÁ; Suarez-Cuartin G; Boza-Hernandez E; Riera-Mestre A; Parra-Martínez A; Colobran R; Antolí A; Navarro S; Rocamora-Blanch G; Framil M; Calatayud L; Corbella X; Casanova JL; Morandeira F; Sabater-Riera J
    J Clin Immunol; 2021 Nov; 41(8):1733-1744. PubMed ID: 34570326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital.
    Chauvineau-Grenier A; Bastard P; Servajean A; Gervais A; Rosain J; Jouanguy E; Cobat A; Casanova JL; Rossi B
    J Clin Immunol; 2022 Apr; 42(3):459-470. PubMed ID: 35083626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 triggering autoimmune diseases.
    Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
    Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 infection: a possible induction factor for development of autoimmune diseases?
    Saeedi N; Gohari NSF; Ghalibaf AAM; Dehghan A; Owlia MB
    Immunol Res; 2023 Aug; 71(4):547-553. PubMed ID: 37316687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus flare following SARS-CoV2 infection: the implication of IFNα and anti-IFNα autoantibodies.
    Mageau A; Nicaise Roland P; Goulenok T; Farkh C; Charles N; Sacre K
    Clin Exp Rheumatol; 2022 Jul; 40(7):1450. PubMed ID: 35238761
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia.
    Philippot Q; Fekkar A; Gervais A; Le Voyer T; Boers LS; Conil C; Bizien L; de Brabander J; Duitman JW; Romano A; Rosain J; Blaize M; Migaud M; Jeljeli M; Hammadi B; Desmons A; Marchal A; ; ; Mayaux J; Zhang Q; Jouanguy E; Borie R; Crestani B; Luyt CE; Adle-Biassette H; Sene D; Megarbane B; Cobat A; Bastard P; Bos LDJ; Casanova JL; Puel A
    J Clin Immunol; 2023 Aug; 43(6):1093-1103. PubMed ID: 37209324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mosaic of autoimmunity - Finally discussing in person. The 13
    Mahroum N; Elsalti A; Alwani A; Seida I; Alrais M; Seida R; Esirgun SN; Abali T; Kiyak Z; Zoubi M; Shoenfeld Y
    Autoimmun Rev; 2022 Oct; 21(10):103166. PubMed ID: 35932955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the intricacies of COVID-19: Autoimmunity, multi-organ manifestations and the role of autoantibodies.
    Ding Z; Wei X; Pan H; Shi H; Shi Y
    Scand J Immunol; 2024 Feb; 99(2):e13344. PubMed ID: 39007954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation.
    Darmarajan T; Paudel KR; Candasamy M; Chellian J; Madheswaran T; Sakthivel LP; Goh BH; Gupta PK; Jha NK; Devkota HP; Gupta G; Gulati M; Singh SK; Hansbro PM; Oliver BGG; Dua K; Chellappan DK
    Environ Sci Pollut Res Int; 2022 Aug; 29(36):54072-54087. PubMed ID: 35657545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
    Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
    J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and autoimmune diseases: is there a connection?
    Votto M; Castagnoli R; Marseglia GL; Licari A; Brambilla I
    Curr Opin Allergy Clin Immunol; 2023 Apr; 23(2):185-192. PubMed ID: 36728317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nervous system-related tropism of SARS-CoV-2 and autoimmunity in COVID-19 infection.
    Weissert R
    Eur J Immunol; 2024 Jan; 54(1):e2250230. PubMed ID: 37733584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive myositis-specific autoantibodies during COVID-19: a case report.
    Abdelkrim AB; Ghozzi M; Saad G; Melayah S; Ach T; Ghedira I; Ach K
    Pan Afr Med J; 2022; 43():181. PubMed ID: 36915412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
    Mohkhedkar M; Venigalla SSK; Janakiraman V
    Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of autoantibodies in COVID-19 convalescents.
    Dobrowolska K; Zarębska-Michaluk D; Poniedziałek B; Jaroszewicz J; Flisiak R; Rzymski P
    J Med Virol; 2023 Jun; 95(6):e28864. PubMed ID: 37310140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.